hy0001a
mAbexperimentalADC
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 10, 2025 (NCT07069062)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearINHIBITOR
Unclear inhibitor
Chemistry & pharmacology
- Payload
- MMAE
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07265206 | Early Phase 1 (Phase 1) | Dec 30, 2025 | Capital Medical University, Juventas Therapeutics, Inc. |
| NCT07069062 | Phase 1/Phase 2 (Phase 2) | Jul 10, 2025 | Government of China, Peking University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Government of China | Government | 1 | 1 | 1 | 2025 |
| Juventas Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2025 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2025 |
4 organizations
Page 1 / 1